Inicio>>Ublituximab

Ublituximab (Synonyms: LFB-R603; TG-1101; TGTX-1101)

Catalog No.GC70083

Ublituximab (LFB-R603; TG-1101; TGTX-1101) es un anticuerpo monoclonal quimérico de próxima generación tipo 1 que se dirige a un sitio único en el antígeno CD20. Ublituximab tiene propiedades anti-cancerígenas.

Products are for research use only. Not for human use. We do not sell to patients.

Ublituximab Chemical Structure

Cas No.: 1174014-05-1

Tamaño Precio Disponibilidad Cantidad
5mg
702,00 $
Disponible
10mg
1.125,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Reseñas

Review for Ublituximab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ublituximab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.